
|Videos|January 6, 2018
Immunotherapy Progress in the Treatment of CRC
Author(s)John L. Marshall, MD
John L. Marshall, MD, chief, Division of Hematology/Oncology, Medstar Georgetown University Hospital, director, Otto J. Ruesch Center for the Cure of Gastrointestinal Cancer, discusses the progress that has been made with immunotherapy in the treatment of colorectal cancer.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Daratumumab for Smoldering Multiple Myeloma
2
FDA Grants Orphan Drug Status to Novel CD33-Directed Immunotherapy for AML
3
Domvanalimab Combo Shows Enriched First-Line Efficacy in Advanced GI Cancers
4
Talquetamab Combo Yields High Responses in Heavily Pretreated Myeloma
5








































